In a cohort of over 1000 patients with lymphogenously metastasized BC, biomarker validation revealed a significant correlation between p4E-BP1T37/46 and p62 in HR+/Her2− BC (Fig. 8b). Here, SQSTM1 is linked to breast cancer.